Royal Cornwall Hospitals NHS Trust

Specialist MDT: Plymouth Hospitals NHS Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • Whole body MRI
    • Isotope bone scan
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • External beam radiotherapy (EBRT)
    • Chemotherapy
    • Clinical trials unit
  • Support Service Facilities:
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here. Please note: the data quality results were amended in May 2022.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 434 837
Performance Status recorded 68% 57%
TNM completed 71% 79%
Stage variable assigned 89% 94%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 817 34801
Percentage of men diagnosed with metastatic disease 22% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

Outcome

Treatment Centre
No. of men who received radical radiotherapy (2018) 46
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 15%

Compare provider outcomes